PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer.

ABSTRACT:

SUBMITTER: Liang H 

PROVIDER: S-EPMC9196060 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature